Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in HRMY — Harmony Biosciences Holdings, Inc.

CIK 1423053 MIAMI, FL
Back to HRMY Full portfolio

Position in HRMY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,314,042
-$7,089,257 QoQ
Shares Held
255,810
-56.3% QoQ
Ownership
0.439%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#43
of 328 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HRMY Over Time

Shares Held

Position Value (USD)

Derivatives in HRMY

reported options exposure · as of Jun 30, 2026
CallValue
$1,572,912
CallShares
43,200
PutValue
$757,328
PutShares
20,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. HRMY ranks #102 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in HRMY

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,572,912 43,200
2026-06-30 $9,314,042 255,810
2026-06-30 $757,328 20,800
2026-03-31 $1,005,559 35,900
2026-03-31 $16,403,299 585,623
2026-03-31 $1,571,361 56,100
2025-12-31 $2,263,910 60,500
2025-12-31 $15,731,741 420,410
2025-12-31 $1,025,308 27,400
2025-09-30 $633,880 23,000
2025-09-30 $1,874,410 68,012
2025-09-30 $2,791,828 101,300
2025-06-30 $897,440 28,400
2025-06-30 $214,880 6,800
2025-03-31 $205,778 6,200
2025-03-31 $358,452 10,800
2025-03-31 $28,623,255 862,406
2024-12-31 $467,976 13,600
2024-12-31 $719,169 20,900
2024-12-31 $47,080,862 1,368,232
2024-09-30 $28,000 700
2024-09-30 $712,000 17,800
2024-09-30 $6,187,040 154,676
2024-06-30 $20,645,874 684,318
2024-06-30 $66,374 2,200
2024-06-30 $503,839 16,700
2024-03-31 $265,282 7,900
2024-03-31 $594,366 17,700
2024-03-31 $19,530,799 581,620
2023-12-31 $607,240 18,800
2023-12-31 $733,210 22,700
2023-12-31 $2,543,075 78,733
2023-09-30 $7,932,961 242,080
2023-09-30 $127,803 3,900
2023-09-30 $1,386,171 42,300
2023-06-30 $242,811 6,900
2023-06-30 $1,273,878 36,200
2023-06-30 $28,182,262 800,860
2023-03-31 $669,325 20,500
2023-03-31 $780,335 23,900
2023-03-31 $17,363,498 531,807
2022-12-31 $82,650 1,500
2022-12-31 $7,491,009 135,953
2022-12-31 $269,990 4,900
2022-09-30 $6,386,749 144,203
2022-09-30 $3,791,224 85,600
2022-06-30 $1,638,672 33,600
2022-06-30 $3,582,790 73,463
2022-03-31 $8,196,503 168,479
2021-12-31 $3,855,977 90,431

Report a Problem

Category
Description
Email (optional, for follow-up)